|Purification and biochemical characterization of pancreatic phospholipase A2 from the common stingray Dasyatis pastinaca.|
|Jump to Full Text|
|PMID: 21329523 Owner: NLM Status: MEDLINE|
|BACKGROUND: Mammalian sPLA2-IB are well characterized. In contrast, much less is known about aquatic ones. The aquatic world contains a wide variety of living species and, hence represents a great potential for discovering new lipolytic enzymes.
RESULTS: A marine stingray phospholipase A2 (SPLA2) was purified from delipidated pancreas. Purified SPLA2, which is not glycosylated protein, was found to be monomeric protein with a molecular mass of 14 kDa. A specific activity of 750 U/mg for purified SPLA2 was measured at optimal conditions (pH 8.5 and 40 °C) in the presence of 4 mM NaTDC and 8 mM CaCl2 using PC as substrate. The sequence of the first twenty first amino-acid residues at the N-terminal extremity of SPLA2 was determined and shows a close similarity with known mammal and bird pancreatic secreted phospholipases A2. SPLA2 stability in the presence of organic solvents, as well as in acidic and alkaline pH and at high temperature makes it a good candidate for its application in food industry.
CONCLUSIONS: SPLA2 has several advantageous features for industrial applications. Stability of SPLA2 in the presence of organic solvents, and its tolerance to high temperatures, basic and acidic pH, makes it a good candidate for application in food industry to treat phospholipid-rich industrial effluents, or to synthesize useful chemical compounds.
|Abir Ben Bacha; Aida Karray; Emna Bouchaala; Youssef Gargouri; Yassine Ben Ali|
Related Documents :
|12443773 - Nitrite-mediated decarboxylative conjugation of caffeic acid with glutathione under mil...
2122243 - Inhibition of benzo[a]pyrene dihydrodiol epoxide mutagenicity by synthetic analogues of...
6785523 - Acute hereditary tyrosinaemia type i: clinical, biochemical and haematological studies ...
|Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2011-02-17|
|Title: Lipids in health and disease Volume: 10 ISSN: 1476-511X ISO Abbreviation: Lipids Health Dis Publication Date: 2011|
|Created Date: 2011-03-07 Completed Date: 2011-06-16 Revised Date: 2013-06-30|
Medline Journal Info:
|Nlm Unique ID: 101147696 Medline TA: Lipids Health Dis Country: England|
|Languages: eng Pagination: 32 Citation Subset: IM|
|Laboratoire de Biochimie et de Génie Enzymatique des Lipases, ENIS route de Soukra, BP1173, University of Sfax, 3038 Sfax, Tunisia.|
|APA/MLA Format Download EndNote Download BibTex|
Amino Acid Sequence
Calcium / pharmacology
Group IB Phospholipases A2 / isolation & purification*, metabolism
Pancreas / enzymology
|7440-70-2/Calcium; EC 126.96.36.199/Group IB Phospholipases A2|
Journal ID (nlm-ta): Lipids Health Dis
Publisher: BioMed Central
Copyright ©2011 Bacha et al; licensee BioMed Central Ltd.
Received Day: 25 Month: 1 Year: 2011
Accepted Day: 17 Month: 2 Year: 2011
collection publication date: Year: 2011
Electronic publication date: Day: 17 Month: 2 Year: 2011
Volume: 10First Page: 32 Last Page: 32
Publisher Id: 1476-511X-10-32
PubMed Id: 21329523
|Purification and biochemical characterization of pancreatic phospholipase A2 from the common stingray Dasyatis pastinaca|
|Abir Ben Bacha1||Email: email@example.com|
|Aida Karray1||Email: firstname.lastname@example.org|
|Emna Bouchaala1||Email: email@example.com|
|Youssef Gargouri1||Email: firstname.lastname@example.org|
|Yassine Ben Ali1||Email: email@example.com|
1Laboratoire de Biochimie et de Génie Enzymatique des Lipases, ENIS route de Soukra, BP1173, University of Sfax - 3038 Sfax, Tunisia
Phospholipases A2 (PLA2) comprise a set of extracellular and intracellular enzymes that catalyze the hydrolysis of the sn-2 fatty acyl bond of phospholipids to yield fatty acids and lysophospholipids . The intracellular PLA2 s are divided into cPLA2 (cytosolic calcium dependent, group IV) and iPLA2 (cytosolic calcium independent, group VI), based on the Ca2+ requirements needed for basal activity. cPLA2 requires micromolar Ca2+ for membrane translocation but not for catalysis, possesses a preference for phospholipids containing AA, and have high molecular mass (> 60 kDa). iPLA2 exhibits no substrate specificity for AA-containing phospholipids and no Ca2+ requirement for activity and has high molecular mass (about 85 kDa) [1-3]. The extracellular (secreted) PLA2 s (sPLA2) have low molecular masses (13-18 kDa), require millimolar calcium concentrations for catalytic activity, and do not manifest significant fatty acid selectivity in vitro. To date, 11 forms of mammal sPLA2 have been identified and classified according to their origin, sequence similarity and molecular mass as well as substrate specificity into groups IB, IIA, IIC, IID, IIE, IIF, V, X, III, XIIA and XIIB [4,5]. There is also a class of PLA2 s called platelet-activating factor (PAF) acetylhydrolases .
sPLA2-IB is also known as the pancreatic-type PLA2. It is synthesized by the pancreatic acinar cells, and after secretion as a zymogen into the pancreatic juice, an N-terminal heptapeptide of the inactive zymogen is cleaved by trypsin to yield an active enzyme in the duodenum.
sPLA2-IB is also highly expressed in the stomach and is present at lower levels in lung, spleen, liver, colon and eyes [7-9]. Receptors for this enzyme have been identified in various tissues, and group IB PLA2 is now reported to play a role in cell proliferation and hormone release via these receptors in non-digestive tissues [7,10,11]. These findings reveal the physiological importance of group IB PLA2 in non-digestive tissues, in addition to digestive lipolysis in the intestinal tract.
Cartilaginous fish, represented by sharks, skates and rays, are generally considered as the most primitive living jawed vertebrates. They first appeared during the Ordovician period about 450 million years ago sharing a common ancestor with a jawed vertebrate ancestor, placoderm. The extinction of placoderm at Devonian-Carboniferous boundary makes cartilaginous fish the oldest taxa of extant jawed vertebrates, pushing them to the edge of jawless-jawed transition. To date, the cartilaginous fish are also the oldest vertebrates possessing a complex digestif system like mammals .
Mammalian sPLA2-IB are well characterized [13-20] and recently some studies are carried on bird PLA2 [21-23]. In the contrast, much less is known about aquatic ones [24-30]. The aquatic world contains a wide variety of living species and, hence represents a great potential for discovering new enzymes. It is therefore interesting to study some catalytic and biochemical properties of a purified marine PLA2 to gain more insights into their action mode on phospholipids. This paper reports, for the first time, the purification of phospholipase A2 from the same organ. This phospholipase tentatively named stingray pancreatic phospholipase A2 (SPLA2) was characterized using the emulsified system.
No phospholipase activity was detected in freshly crude extract of delipidated pancreas of stingray using PC emulsions (Figure 1). The maximum PLA2 activity was obtained after incubation at room temperature during 40 min, PLA2 activity did not increase when exogenous trypsin was added at different ratios to the homogenate solution then endogenous proteases are sufficient to achieve PLA2 activation (data not shown).
It has emerged from several kinetic studies on phospholipases A2 that the N-terminal propeptide may play an important role in the expression of the maximum catalytic activity measured in vitro .
The most illustrative example was reported by de Haas' group on pancreatic phospholipase A2, which is known to be secreted by the pancreas as a zymogen which is highly active on water soluble short chain phospholipids, but not able to hydrolyse long chain phospholipids present at the interface. Limited proteolysis by trypsin of the Arg7-Ala8 peptide bond transforms the inactive zymogen into an active enzyme .
20 grams of delipidated powder of the stingray pancreas was suspended in 300 ml 50 mM Tris-HCl buffer, pH 8.5, containing 0.05% Triton X-100 and 150 mM NaCl (buffer A) and ground mechanically twice for 30 s using the Waring Blendor system. The mixture was stirred with a magnetic bar for 45 min at room temperature and then centrifuged for 30 min at 12,000 rpm. The supernatant contained 450 PLA2 units per gram of delipidated pancreatic tissue.
In contrast to marine snail (mSDPL) and crab (CDPL) digestive phospholipases purified recently in our laboratory [28,30], SPLA2 present in the homogenate can tolerate, without any denaturation, the incubation at high temperature. The stingray extract PLA2 solution was incubated 15 min at 65 °C. After rapid cooling, insoluble denatured proteins were removed by centrifugation during 30 min at 12,000 rpm. Afterward, the pH of the previous supernatant was brought to 3.0 by adding 6 N HCl under gentle stirring at 0°C. After centrifugation (30 min at 12,000 rpm), the clear supernatant, which was adjusted to pH 7 with 6 N NaOH, contained 85% of starting amount of PLA2.
The treated supernatant (250 ml, 7650 U) was brought to 70% saturation with solid ammonium sulphate under stirring conditions and maintained during 45 min at 4 °C. After centrifugation (30 min at 12.000 rpm), the precipitated PLA2 was resuspended in 10 ml of buffer A containing 2 mM benzamidine. Insoluble material was removed by centrifugation during 10 min at 12.000 rpm. Approximately 68% of the starting amount of PLA2 was recovered.
An equal volume of pure ethanol solution was added to the supernatant (10 ml, 6120 U) at 0 °C. Precipitated proteins were removed by centrifugation and the supernatant was added slowly with four times its volume of ethanol to bring the alcohol concentration to 90% (v/v) at 0 °C. After centrifugation for 30 min at 12.000 rpm the ethanol precipitated PLA2, which contains about 50% of the enzyme starting amount, was solubilized in of 100 mM acetate buffer pH 4.5 containing 0.05% TX-100 and 2 mM benzamidine (buffer B). In the present study, we found this step critical to eliminate the last traces of lipids facilitating the filtration chromatography step.
The PLA2 sample was submitted to gel filtration through a Sephadex G-50 column (95 cm × 2.6 cm) equilibrated with buffer B. Elution of proteins was performed with the same buffer at 30 ml/h. The fractions containing the PLA2 activity eluted between 1.5 and 2 void volumes were pooled together (data not shown).
The pooled active fractions of Sephadex G-50 column were applied to a Mono-S column (2.6 cm × 20 cm) equilibrated with buffer B. Non fixed proteins were washed out with 0.1 M NaCl in buffer B. The elution of the adsorbed proteins was then performed with a linear gradient of NaCl (0.1 to 0.4 M). As shown in the elution diagram, SPLA2 activity emerged in a single peak (Figure 1A) at 0.27 M NaCl. The fractions of this peak were pooled, lyophilized and then dialyzed over night at 4 °C against 25 mM Tris HCl buffer pH 8 containing 25 mM NaCl and 2 mM benzamidine (buffer C). The recovery of PLA2 from Mono-S column was of about 45% of the starting amount of the enzyme.
Dialyzed active fractions were subjected to anion-exchange chromatography using a Mono-Q column (1.5 cm × 20 cm) equilibrated with buffer. The column was rinsed with 100 ml of buffer C containing 100 mM NaCl allowed to eliminate a first peak with high absorbance. SPLA2 was eluted from Mono-Q Sepharose upon a single wash with the same buffer containing 200 mM NaCl. One peak was then obtained and only 8 fractions containing pure SPLA2 were pooled (figure 1B). Active fractions were pooled and lyophilized. At this stage of purification, the enzyme presented a specific activity of 550 U/mg.
Thirty units of lyophilized sample from Mono-Q column were applied to RP-HPLC eurospher 100, C-8 column (250 mm × 4.6 mm). PLA2 activity was detected in a fraction eluted at 70% acetonitrile as a single peak (Figure 2A) and the overall recovery of the enzyme activity was 23% of the starting amount.
The purification flow sheet given in Table 1 shows that the specific activity of pure SPLA2 reached 750 U/mg, when PC or egg yolk emulsions were used as substrates at pH 8.5, 40 °C and in the presence of 4 mM NaTDC and 8 mM CaCl2. The fractions containing the SPLA2 activity were pooled and analysed on SDS-PAGE (Figure 2B). This figure shows that SPLA2 is homogenously pure and has an apparent molecular mass of 14 kDa. This result was in line with the molecular mass determined under native conditions, using gel filtration on FPLC column Superdex 75 (1 × 30 cm) (data not shown). These data suggested that SPLA2 was a monomeric protein like all the sPLA2 described in previous works [13-23].
Purified SPLA2 was denaturated, reduced and alkylated as described in Section 2 and dialysed against distilled water. The NH2-terminal sequencing of the PVDF transferred band from an electrophoretic gel allowed unambiguously the identification of the twenty first N-terminal residues of SPLA2. The same sequences were obtained when the pure SPLA2 was transferred without alkylation on a PVDF membrane. Result presented in Table 2 shows the N-terminal sequence, of SPLA2, together with those of dromedary , turkey , ostrich  and chicken  PLA2. N-terminal sequence of marine PLA2 exhibits a high degree of homology with N-terminal sequences of mammal and bird ones. However, no similarity of the CDPL  and mSDL  N-terminal amino acid sequences with known digestive phospholipases was found.
Phospholipase activity was tested at temperatures ranging from 20 to 55 °C using homogeneous PC emulsion as substrate (figure 3A). For the sake of comparison we also report the results for dromedary and ostrich pancreatic phospholipases in Figure 2. The maximal SPLA2 activity was measured at 40 °C. This optimum was similar to that of mammal and bird pancreatic PLA2, like dromedary , chicken  and ostrich  but less than those of the PLA2 from the pyloric ceca of starfish A. pectinifera , CDLA  and mSDPL  which had optimal temperatures around 50 °C.
The thermostability of SPLA2 was also investigated by measuring the residual activity after incubation of the pure enzyme at 70°C in buffer at different times (Figure 3B). In contrast to mSDPL, CDLA  and TPLA2 , which lose their full activities when incubated at 55 °C during a few minutes, PLA2 purified from stingray pancreas can tolerate the incubation at high temperature and maintained about 75% of its activity after 5 min incubation at 70 °C. Similar behavior was obtained with dromedary (DrPLA2) taken as model of mammal PLA2 when incubated under the same conditions at 70 °C (Figure 3B). However, marine PLA2 was found, less resistant against temperature than the ostrich PLA2 (OPLA2) taken as a model of bird PLA2. As shown in Figure 3A, pure OPLA2 maintained about 80% of its activity after 20 min incubation at 70 °C.
The pH activity profile of the purified stingray phospholipase A2 is shown in Figure 3C. The pH-optimum of SPLA2 activity was similar to that of DrPLA2 and OPLA2 [20-23]1760. The maximal activity of SPLA2 was measured at pH 8.5 (Figure 3C).
Moreover, the pH stability (Figure 3D) showed that the purified SPLA2 was found to be active between pH 3 and 10 during 10 min of incubation. In contrast to OPLA2 which maintained more than 70% of its activity when incubated at pH 1.5 the pure SPLA2 is not stable at pH less than 3, (Figure 3D). However, the TPLA2 , mSDL  and CDPL  lose their full activity when incubated at pH less than 5 for few minutes.
It is well established that Ca2+ is essential for both, activity and binding of phospholipases to their substrate [34,35]. In order to investigate the effect of Ca2+ on CDPL activity, we studied the variation of the PC emulsion hydrolysis rates by homogeneous SPLA2 in presence of various Ca2+ concentrations (Figure 4A). For further comparison, we reported in the same Figure 4A the results obtained with DrPLA2 and OPLA2. Our results show that PLA2 activity could not be detected in the presence of chelator such as EDTA or EGTA when pure PC or egg yolk emulsion was used as substrate. The specific activity of SPLA2 increased to reach its maximum in the presence of 8 mM Ca2+ using PC as substrate (figure 4A). Similar results were obtained with mSDPL  and CDPL . This Ca2+ concentration is also needed to activate mammal and bird pancreatic PLA2 [20-23].
Several studies have provided evidence that bile salts are tensioactive agents ensuring in micellar form, the dispersion of the hydrolysis products and thus increase the hydrolysis rate. De Haas et al. (1970)  reported that micellar forms of the substrate were hydrolyzed by PLA2 at a much higher rate than molecularly dispersed substrates. In order to investigate the effect of bile salts on SPLA2 activity, the rate of hydrolysis of PC by SPLA2 with various concentrations of bile salts, at pH 8.5 and at 40 °C, was studied. As shown in figure 4C and 4D, sodium Taurodeoxycholate (NaTDC) and sodium deoxycholate (NaDC) were specifically required for SPLA2 activity. The maximum phospholipase activity was observed in the presence of 4 mM NaTDC or 6 mM NaDC. These observations corroborate with previous findings with mammals, bird pancreatic PLA2 [20-23].
To determine the kinetic parameters of SPLA2, the rate of hydrolysis of different concentrations of PC were measured under optimal conditions (4 mM NaTDC, 8 mM, CaCl2, pH 8,5 and 40 °C). The Lineweaver-Burk curves were plotted (data not shown). From these fits, the substrate affinity constants (KM) and the turnover of the enzymatic reaction (kcat) were obtained and shown with the deduced catalytic efficiency (kcat/KM) in Table 3. For further comparison, we reported in the same Table 3 the kinetic parameters values obtained with DrPLA2, under the same conditions. From these values, one can say that SPLA2 hydrolyses the PC substrate more efficiently than SPLA2 since the ratio representing the catalytic efficiency (Kcat/Km) is about 2 times higher with SPLA2 than with DrPLA2.
Organic solvents can be advantageous in various industrial enzymatic processes. The use of organic solvents can increase the solubility of non-polar substrates, increase the thermal stability of enzymes, decrease water-dependent side reactions, or eliminate microbial contamination . In this study, the SPLA2 showed high stability in the presence of water-miscible organic solvents, since it retained almost 100% activity after exposure, for 2 h at 25 °C, to 50% methanol, 50% ethanol, 50% 2-propanol, 50% acetonitrile or 50% acetone (Table 4). Addition of 50% ethanol or 50% acetonitrile to the pure SPLA2 caused a 12% immediate increase of the PLA2 activity in comparison to the control.
In the course of the long-term stability experiment, the activity of SPLA2, which was stored at room temperature, did not decrease within the two first days (Figure 3). During the first week, activity did not drop below 90% of initial values. Later on, a continuous decrease was evident towards 50% of initial activity after 120 days. In contrast, the samples stored in the refrigerator maintained more than 90% of initial activity after 120 days. In conclusion, SPLA2 activity remained surprisingly stable up to 40 weeks, although SPLA2 was not maintained in a stability-enhancing medium, e.g. supplements of Ca2+, glycerol, or ammonium sulphate, but just in plain demineralized water.
Benzamidine was from Fluka (Buchs, Switzerland), bovine serum albumine (BSA), sodium deoxycholate (NaDC), sodium taurodeoxycholate (NaTDC), Triton X-100 (TX-100) and phosphatidylcholine (PC) were from Sigma Chemical (St. Louis, USA), acrylamide and bis-acrylamide electrophoresis grade were from BDH (Poole, UK). Marker proteins and the chromatography supports, used for PLA2 purification: Sephadex G-50, Mono-S, Mono-Q were Pharmacia (Uppsala, Sweden).). PVDF membrane and protein sequencer Procise 492 equipped with 140 C HPLC system purchased from Applied Biosystems (Roissy, France). C-8 reverse-phase eurospher 100 column was from Knauer (Germany). pH-stat was from Metrohm (Herisau, Switzerland).
Stingrays (Dasyatis pastinaca) pancreases were collected from a local fish market (Sfax, Tunisia) and stored at -20°C.
The stingray PLA2 activity was measured titrimetrically at pH 8.5 and at 40 °C with a pH-stat, under the optimum conditions, using purified egg PC or a crude egg yolk emulsions as substrate in the presence of 4 mM NaTDC and 8 mM CaCl2 . Some assays were performed with NaDC. One unit of phospholipase activity was defined as 1 μmole of fatty acid liberated under standard conditions.
In order to check the thermal stability of SPLA2, homogeneous enzyme was incubated successively at 70 °C for different durations. The pH stability of SPLA2 was studied at room temperature during 30 min using the following buffers: 50 mM sodium acetate buffer (pH 4-6), 50 mM potassium phosphate buffer (pH 6-8), 50 mM Tris-HCl buffer (pH 7-10). After each incubation, residual phospholipase activity was measured after centrifugation of the sample, under optimal conditions.
Protein concentration was determined as described by Bradford (1976) using BSA (E1%1 cm = 6.7) as reference .
The presence of glycan chains in the purified cofactors was checked by the anthrone-sulfuric acid method using glucose as a standard . One milliliter of each pure SPLA2 (1 mg/ml in Tris-HCl buffer) was mixed with 4 ml of distilled water in screw cap type culture tube. The tube was then placed on ice to cool. Then, we added 10 ml of cold anthrone reagent (0.2 g in 100 ml concentrated H2SO4) prepared fresh daily. After mixing, we placed a marble on top of the tube to prevent evaporation and we incubated in a boiling water bath during 16 min, afterwards, the tube was cooled on ice for 2-3 min then at room temperature for 5-10 min. Finally, we read the absorbance at 620 nm against a reagent blank. The rate of glycosylation is calculated on the basis of percentage by weight.
The alkylation of cysteine residues of phospholipase was realized as described by Okazaki et al. (1985) . Hundred picomoles of SPLA2 in 1 ml of 10 mM Tris-HCl, pH 8 were denatured in 185 μl of 8 M guanidine hydrochloride, 65 μl of 1 M Tris-HCl, 4 mM EDTA (pH 8.5) and 80 mM DTT for 30 min at 60 °C. S-Pyridylethylation of cysteine residues of protein was performed by adding 4 μl of vinyl pyridine and incubation at 25 °C for 3 h. The modified enzyme was dialyzed against water for N-terminal sequencing.
Analytical polyacrylamide gel electrophoresis of proteins in the presence of sodium dodecyl sulfate (SDS-PAGE) was performed by the method of Laemmli (1970) . The proteins were stained with Coomassie brilliant blue.
For N-terminal sequencing, the purified enzyme was blotted (60 min, 50 mA, 4 °C) onto a PVDF (polyvinylidene difluoride) membrane (Applied Biosystems, ProBlotTM) in 20 mM CAPS buffer (pH 11) containing 10% methanol using a mini trans-blot cell (BioRad, Hercules, USA). The N-terminal sequence was determined by automated Edman's degradation, using an Applied Biosystems Protein Sequencer Procise 492 equipped with 140 C HPLC system (Roissy, France) .
Described here is the purification and the characterization of a new phospholipase A2 from stingray pancreas. This phospholipase has several advantageous features for industrial applications. Stability of SPLA2 in the presence of organic solvents, and its tolerance to high temperatures, basic and acidic pH, makes it a good candidate for application in food industry to treat phospholipid-rich industrial effluents, or to synthesize useful chemical compounds.
AA: Arachidonic acid; DrPLA2: dromedary phospholipase A2; kcat: the turnover of the enzymatic reaction; KM: substrate affinity constants; NaTDC: sodium taurodeoxycholate; OPLA2: ostrich phospholipase A2; PLA2: phospholipase A2; SPLA2: stingray phospholipase A2, sPLA2-IB: secreted pancreatic phospholipase A2;
The authors declare that they have no competing interests.
ABB and AK carried out all the studies, analyzed the data and drafted the manuscript. EB helped with the analysis of the data. YG helped with the discussion of the data and the correction of the manuscript. YBA participated in the study design and helped to draft the manuscript. All authors have read and approved the final manuscript.
This work was supported by DGRST granted to the "Laboratoire de Biochimie et de Génie Enzymatique des Lipases". The authors would like to thank to Mr. Chedly Youssfi (FSS) for his technical assistances. Our thanks are due to Pr H. Mejdoub (FSS, Tunisia) for the sequencing of the NH2-terminal of SLA2.
|Balsinde J,Winstead MV,Dennis EA,Phospholipase A2 regulation of arachidonic acid mobilizationFEBS LettYear: 20025312610.1016/S0014-5793(02)03413-012401193|
|Chakraborti S,Phospholipase A2 isoforms: a perspectiveCell SignallingYear: 20031563766510.1016/S0898-6568(02)00144-412742226|
|Balsinde J,Balboa MA,Insel PA,Dennis EA,Regulation and inhibition of phospholipase A2Annu Rev Pharmacol ToxicolYear: 19993917518910.1146/annurev.pharmtox.39.1.17510331081|
|Murakami M,Kudo I,Diversity and regulatory functions of mammalian secretory phospholipase A2sAdvances in ImmunologyYear: 200177163194 full_text. 11293116|
|Valentin E,Lambeau G,Increasing molecular diversity of secreted phospholipases A2 and their receptors and binding proteinsBiochim Biophys ActaYear: 20001488597011080677|
|Derewenda ZS,Ho YS,PAF-acetylhydrolasesBiochim Biophys ActaYear: 1999144122923610570251|
|Valentin E,Ghomashchi F,Gelb MH,Lazdunski M,Lambeau G,On the diversity of secreted phospholipases A2. Cloning, tissue distribution, and functional expression of two novel mouse group II enzymesJ Biol ChemYear: 1999274311953120210.1074/jbc.274.44.3119510531313|
|Mandal AK,Zhang Z,Chou JY,Zimonjic D,Keck CL,Popescu N,Mukherjee AB,Molecular characterization of murine pancreatic phospholipase A(2)DNA Cell BiolYear: 20012014915710.1089/10445490130006898811313018|
|Kolko M,Prause JU,Bazan NG,Heegaard S,Human secretory phosp holipase A(2), group IB in normal eyes and in eye diseasesActa Ophthalmol ScandYear: 20078531732310.1111/j.1600-0420.2006.00809.x17488462|
|Hanasaki K,Yokota Y,Ishizaki J,Itoh T,Arita H,Resistance to endotoxic shock in phospholipase A2 receptor-deficient miceJ Biol ChemYear: 1997272327923279710.1074/jbc.272.52.327929407054|
|Lambeau GH,Cupillard L,Ladzunski M,Lambeau GH, Cupillard L and Ladzunski MJMembrane receptors for venom phospholipase A2Venom Phospholipase A2 Enzymes: Structure, Function and MechanismYear: 1997Wiley & Sons, Chichester389412|
|Kobeghenova SS,Morphology and morphogenesis of the digestive system of some cartilaginous fishes (Chondrichthyes)Zoological journalYear: 199271108122|
|Hanasaki K,Yakota Y,Ishizaki J,Johnson LK,Resistance to endotoxic shock in phospholipase A2 receptor-deficient miceJ Biol ChemYear: 19972723279210.1074/jbc.272.52.327929407054|
|Nieuwenhuizen W,Kunze H,de Haas GH,Phospholipase A2 (phosphatide acylhydrolase EC 188.8.131.52) from porcine pancreasMethods EnzymolYear: 1974321147 full_text.|
|Abita JP,Lazdunski M,Bonsen PPM,Pieterson WA,de Haas GH,Zymogen-enzyme transformations. On the mechanism of activation of prophospholipase AEur J BiochemYear: 1972303710.1111/j.1432-1033.1972.tb02069.x4673648|
|Arnesjö B,Barrowman J,Borgström B,The zymogen of phospholipase A2 in rat pancreatic juiceActa Chem ScandYear: 19672128975585689|
|Figarella C,Clemente F,Guy O,A zymogen of phospholipase A in human pancreatic juiceBiochem Biophys ActaYear: 19712272135543591|
|Dutilh E,Van Doren PJ,Verheul EE,de Haas GH,Isolation and Properties of Prophospholipase A2 from Ox and Sheep PancreasEur J BiochemYear: 1975539110.1111/j.1432-1033.1975.tb04045.x|
|Evenberg A,Meyer H,Verheij HM,de Haas GH,Isolation and properties of prophospholipase A2 and phospholipase A2 from horse pancreas and horse pancreatic juiceBiochim Biophys ActaYear: 1977491265849461|
|Ben Bacha A,Gargouri Y,Bezzine S,Mejdoub H,Purification and biochemical characterization of phospholipase A2 from dromedary pancreasBiochim Biophys ActaYear: 20061760120216733083|
|Ben Salah R,Zouari N,Reinbolt J,Mejdoub H,Purification of turkey pancreatic phospholipase A2Biotechnol BiochemYear: 200367213910.1271/bbb.67.2139|
|Ben Bacha A,Gargouri Y,Bezzine S,Mosbah H,Mejdoub H,Ostrich pancreatic phospholipase A2: Purification and biochemical characterizationJournal of Chromatography BYear: 200785710811410.1016/j.jchromb.2007.07.012|
|Karray A,Frikha F,Ben Bacha A,Ben Ali Y,Gargouri Y,Bezzine S,Biochemical and molecular characterization of purified chicken pancreatic phospholipase A2FEBS JYear: 20092761645455410.1111/j.1742-4658.2009.07160.x19645724|
|Audley MA,Shetty KJ,Kinsella JE,Isolation and properties of phospholipase A from pollock muscleJ Food SciYear: 1978437711775|
|Neas NP,Hazel JR,Partial purification and kinetic characterization of the microsomal phospholipase A2 from thermally acclimated rainbow trout (Salmo gairdneri)J Comp Physiol BYear: 198515546146910.1007/BF006846763837026|
|Aaen B,Jessen F,Jensen B,Partial purification and characterization of a cellular acidic phospholipase A2 from cod (Gadus morhua)Comp Biochem Physiol BYear: 199511054755410.1016/0305-0491(94)00185-W|
|Zambonino Infante JL,Cahu CL,High dietary lipid levels enhance digestive tract maturation and improve Dicentrarchus labrax larval developmentJ NutrYear: 19991291195120010356086|
|Cherif S,Ben Bacha A,Ben Ali Y,Horchani H,Rekik W,Gargouri Y,Crab digestive phospholipase: a new invertebrate memberBioresour TechnolYear: 201010113667110.1016/j.biortech.2009.07.03119695876|
|Pattus F,Slotboom AJ,de Haas GH,Regulation of Phospholipase A2 Activity by the Lipid-Water Interface: a Monolayer ApproachBiochemistryYear: 1979182703270710.1021/bi00580a003573136|
|Zarai Z,Ben Bacha A,Horchani H,Bezzine S,Gargouri Y,Mejdoub H,A novel marine hepatopancreatic phospholipase A2 with digestive and toxic activitiesArchives of Biochemistry and BiophysicsYear: 2010494212112910.1016/j.abb.2009.11.02019932080|
|Verheij HM,Slotboom AJ,de Haas GH,Structure and function of phospholipase A2Rev Physiol Biochem PharmacolYear: 198191917031820|
|Kishimura H,Hayashi K,Isolation and characteristics of trypsin from pyloric ceca of the starfish Asterina pectiniferaComp Biochem Physiol B Biochem Mol BiolYear: 199912448348810.1016/S0305-0491(99)00142-X|
|Bradford MM,A rapid and sensitive method for the quantification of microgram quantities of proteins utilizing the principle of protein-dye bindingAnal BiochemYear: 19767224825410.1016/0003-2697(76)90527-3942051|
|Scott DL,White SP,Otwinowski Z,Yuan W,Gelb MH,Sigler PB,Crystal structure of bee venom phospholipase A2 in a complex with a transition-state analogueScienceYear: 19912501541154610.1126/science.2274785|
|Fleer EM,Verheij HM,De Haas GH,Modification of arginine residues in bovine pancreatic phospholipase A2, identification of aspartate 49 as Ca2+ binding ligandEur J BiochemYear: 198111328328810.1111/j.1432-1033.1981.tb05064.x7202411|
|De Haas GH,Slotboom A,Bonsen PPM,Van Deenen LLM,Maroux S,Puigserver A,Desnuelle P,Studies on phospholipase A and its zymogen from porcine pancreas: I. The complete amino acid sequenceBiochim Biophys ActaYear: 197022131535528841|
|Heitmann P,Ruttloff HYear: 1994Industrielle Enzyme, Behr's Verlag, Hamburg913|
|Abousalham A,Verger R,Egg yolk lipoproteins as substrates for lipasesBiochim Biophys ActaYear: 20001485566210802249|
|Spiro R,Analysis of sugar found in glycoproteinMethods EnzymolYear: 1966326 full_text.|
|Okazaki K,Yamada H,Imoto T,A convenient S-2 aminoethylation of cysteinyl residues in reduced proteinsAnal BiochemYear: 198514951652010.1016/0003-2697(85)90607-44073506|
|Laemmli UK,Cleavage of structural protein during the assembly of the head of bacteriophage T4NatureYear: 197022768068510.1038/227680a05432063|
|Hewick RM,Hunkapiller MW,Hood LE,A gaz-liquid solid phase peptide and protein sequenatorJ Biol ChemYear: 1981256799079977263636|
Flow sheet of stingray PLA2 purification.
|Total (a) activity (units)||Protein (b)
|Heat and acidic treatment||7650||1050||7.3||72||2.8|
(a) 1 Unit: μmole of fatty acid released per min using PC emulsion as substrate in the presence of 4 mM NaTDC and in the presence of 8 mM CaCl2.
(b) Proteins were estimated by Bradford method (32). The experiments were conducted three times.
Alignment of the N-terminal sequence of SPLA2 with chicken, turkey, ostrich and dromedary PLA2.
Residues in bold indicate identical amino acids.
Apparent kinetic parameters of SPLA2, and dromedary pancreatic phospholipase A2 (DrPLA2).
|Phospholipase||Vmax (U/mg)||Km (mM)||Kcat (s−1)||Kcat/Km (mM−1 s−1)|
stability of SPLA2 in organic solvents.
|Organic solvent||Relative activity% (1 h)||Relative activity% (2 h)|
|Control||100 ± 0.5||100 ± 2.4|
|Acetone||95 ± 2.5||92 ± 2.2|
|Acetonitrile||105 ± 1.5||105 ± 2.3|
|Methanol||98 ± 2.4||95 ± 1.9|
|Ethanol||116 ± 2.7||100 ± 3.3|
|2-Propanol||97 ± 3.1||93 ±3.6|
Pure SPLA2 was incubated in each organic solvent (50%) at 30 °C for 1 or 2 hours.
The experiments were conducted three times.
Previous Document: Genome-wide prediction of discrete traits using Bayesian regressions and machine learning.
Next Document: Genetic educational needs and the role of genetics in primary care: a focus group study with multipl...